Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.

@article{Feliciano2016MetabolicDO,
  title={Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.},
  author={Elizabeth M Cespedes Feliciano and Candyce H Kroenke and Jeffrey A. Meyerhardt and Carla M Prado and Patrick Terrence Bradshaw and Andrew J. Dannenberg and Marilyn L. Kwan and Jingjie Xiao and Charles Patrick Quesenberry and Erin K. Weltzien and Adrienne L. Castillo and Bette Jane Caan},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2016}
}
PURPOSE The effects of obesity and metabolic dysregulation on cancer survival are inconsistent. To identify high-risk subgroups of obese patients and to examine the joint association of metabolic syndrome (MetSyn) in combination with obesity, we categorized patients with early-stage (I to III) colorectal cancer (CRC) into four metabolic categories defined… CONTINUE READING